P3 Health Partners annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
P3 Health Partners Stock-Based Compensation Growth & History (PIII)
P3 Health Partners's stock-based compensation was $5.6M for fiscal 2025.
View full P3 Health Partners company overviewP3 Health Partners annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.6M | −$171,000 | −2.97% |
| 2024 | 2024-12-31 | $5.8M | −$227,000 | −3.80% |
| 2023 | 2023-12-31 | $6.0M | −$13.4M | −69.19% |
| 2022 | 2022-12-31 | $19.4M | — | — |
| 2021 | 2021-12-02 | $3.7M | — | — |
| 2020 | 2020-12-31 | $447,475 | −$26,567 | −5.60% |
| 2019 | 2019-12-31 | $474,042 | — | — |
P3 Health Partners quarterly stock-based compensation
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $866,000 | −$597,000 | −40.81% |
| Q1 2026 | 2026-03-31 | $1.1M | −$757,000 | −41.87% |
| Q4 2025 | 2025-12-31 | $1.1M | $378,000 | +52.43% |
| Q3 2025 | 2025-09-30 | $1.2M | −$747,000 | −38.15% |
| Q2 2025 | 2025-06-30 | $1.5M | −$161,000 | −9.91% |
| Q1 2025 | 2025-03-31 | $1.8M | $359,000 | +24.78% |
| Q4 2024 | 2024-12-31 | $721,000 | −$999,000 | −58.08% |
| Q3 2024 | 2024-09-30 | $2.0M | −$293,000 | −13.02% |
| Q2 2024 | 2024-06-30 | $1.6M | $593,000 | +57.52% |
| Q1 2024 | 2024-03-31 | $1.4M | $472,000 | +48.31% |
| Q4 2023 | 2023-12-31 | $1.7M | −$473,000 | −21.57% |
| Q3 2023 | 2023-09-30 | $2.3M | $467,000 | +26.18% |
| Q2 2023 | 2023-06-30 | $1.0M | −$2.7M | −72.26% |
| Q1 2023 | 2023-03-31 | $977,000 | −$10.7M | −91.66% |
| Q4 2022 | 2022-12-31 | $2.2M | — | — |
| Q3 2022 | 2022-09-30 | $1.8M | $1.4M | +402.40% |
| Q2 2022 | 2022-06-30 | $3.7M | $3.2M | +559.11% |
| Q1 2022 | 2022-03-31 | $11.7M | $11.3M | +2443.02% |
| Q4 2021 | 2021-12-02 | $2.3M | — | — |
| Q3 2021 | 2021-09-30 | $355,093 | — | — |
| Q2 2021 | 2021-06-30 | $563,792 | — | — |
| Q1 2021 | 2021-03-31 | $460,515 | — | — |
P3 Health Partners stock-based compensation trends
Over the last five fiscal years, P3 Health Partners's stock-based compensation increased from $447,475 to $5.6M, a change of $5.1M. The latest reported quarter, Q2 2026, shows $866,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review P3 Health Partners source filings ↗